Wu Luo
Impact in
-
- Natural Compounds in Disease Treatment
- Nephrology top 5%
Papers in
-
- Ubiquitin and proteasome pathways 10
- Inflammasome and immune disorders 6
- Signaling Pathways in Disease 6
- Immunology 19
- Immune cells in cancer 10
- Immune Response and Inflammation 10
- Co-authors
- Guang Liang (64 shared papers)Gaojun Wu (30 shared papers)Guang Liang (17 shared papers)Yi Wang (15 shared papers)Yi Wang (20 shared papers)Weijian Huang (20 shared papers)Jianchang Qian (10 shared papers)Weiwei Zhu (13 shared papers)
In The Last Decade
Wu Luo
89 papers receiving 2.6k citations
Wu Luo's Hit Papers
Peers
Comparison fields: 5 of 113
- Complementary and alternative medicine 215
- Nephrology 136
- Immunology 381
- Pharmacology 152
- Cardiology and Cardiovascular Medicine 360
Countries citing papers authored by Wu Luo
This map shows the geographic impact of Wu Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wu Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wu Luo more than expected).
Fields of papers citing papers by Wu Luo
This network shows the impact of papers produced by Wu Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wu Luo. The network helps show where Wu Luo may publish in the future.
Co-authors
The 25 scholars most cited alongside Wu Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 94 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 225 | |
| 2 | 2018 | 210 | |
| 3 | Celastrol Attenuates Angiotensin II–Induced Cardiac Remodeling by Targeting STAT3 Hit paper breakdown → | 2020 | 202 |
| 4 | 2019 | 135 | |
| 5 | 2020 | 119 | |
| 6 | 2023 | 85 | |
| 7 | 2020 | 80 | |
| 8 | 2022 | 64 | |
| 9 | 1992 | 59 | |
| 10 | 2022 | 56 | |
| 11 | 2023 | 55 | |
| 12 | 2022 | 53 | |
| 13 | 2018 | 52 | |
| 14 | 2019 | 51 | |
| 15 | 2020 | 51 | |
| 16 | 2023 | 48 | |
| 17 | 2020 | 46 | |
| 18 | 2022 | 44 | |
| 19 | 2023 | 37 | |
| 20 | 2022 | 33 |
About Wu Luo
Wu Luo is a scholar working on Molecular Biology, Immunology, Cardiology and Cardiovascular Medicine, Epidemiology and Cancer Research, having authored 94 papers that have together received 2.6k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (10 papers), Immune cells in cancer (10 papers), Immune Response and Inflammation (10 papers), Cardiovascular Function and Risk Factors (10 papers), Cardiac Fibrosis and Remodeling (8 papers), Inflammasome and immune disorders (6 papers), Signaling Pathways in Disease (6 papers) and Advanced Glycation End Products research (6 papers). The work is most often cited by research in Complementary and alternative medicine (215 citations), Nephrology (136 citations), Immunology (381 citations), Pharmacology (152 citations) and Cardiology and Cardiovascular Medicine (360 citations). Wu Luo has collaborated with scholars based in China, Thailand and Canada. Frequent co-authors include Guang Liang, Gaojun Wu, Guang Liang, Yi Wang, Yi Wang, Weijian Huang, Jianchang Qian, Weiwei Zhu, Yiyi Jin and Ke Lin. Their work appears in journals such as Acta Pharmacologica Sinica, International Immunopharmacology, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, Biomedicine & Pharmacotherapy and Phytomedicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.